|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Amortization of intangible assets | |||||
| Restructuring costs | |||||
| Impairment expense | |||||
| Gain from contingent consideration | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense), net | |||||
| Interest expense | |||||
| Derivative warrant liabilities loss | |||||
| Loss on extinguishment of debt | |||||
| Avenue Capital Loan | |||||
| Total loss on extinguishment of debt | |||||
| Loss from continuing operations before income tax expense | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Net income from discontinued operations, net of tax | |||||
| Net loss | |||||
| Basic and diluted weighted-average common shares outstanding (in shares) | |||||
| Net (loss) income per share: | |||||
| Basic and diluted - continuing operations (in dollars per share) | |||||
| Basic and diluted - discontinued operations, net of tax (in dollars per share) | |||||
| Basic and diluted - net loss (in dollars per share) | |||||
Loading...